Factors Associated With Late Antiretroviral Therapy Initiation Among People Living With HIV in Southern Iran: A Historical Cohort Study

Overview

Journal Front Public Health

Specialty Public Health

Date 2022 Jul 5

PMID 35784258

Authors

Sima Afrashteh

Mohammad Fararouei

Haleh Ghaem

Zahra Gheibi

Affiliations

Soon will be listed here.

Abstract

Objectives: Late initiation of antiretroviral therapy (ART) is associated with poor outcome among people living with HIV (PLHIV) and higher risk of transmission of infection. This study was conducted to identify the determinants of late ART initiation among PLHIV in Southern Iran.

Methods: A historical cohort study was conducted on 1,326 PLHIV of ≥15 years of age who were registered with the behavioral diseases counseling center (BDCC) in southern Iran from August 1997 to March 2021. Late ART initiation was defined as a CD4 cell count <200 cells/mm or having a clinical AIDS diagnosis at the time of ART initiation. The required demographic and clinical data were collected from the patients' medical records. Multiple regression analysis was conducted to define late ART initiation associated factors.

Results: Late ART initiation was found among 81.9% of patients. Based on the results of the multivariate analysis, older age (odds ratio [] = 1.02, 95% = 1.00-1.04), being single ( = 1.80, 95% = 1.17-2.78), history of drug use ( = 1.64, 95% = 1.02-2.62), year of ART initiation ( = 3.65, 95% = 2.28-5.86), and possible route of transmission ( = 7.34, 95% = 1.16-46.21) were directly associated with the risk of late ART initiation.

Conclusions: The results show that the prevalence of late ART initiation was alarmingly high. For better infection control and better prognosis of infection, people at high risk need to be provided with timely services (e.g., diagnosis, treatment, training, and social support).

Citing Articles

Factors associated with late initiation of antiretroviral therapy in Iran's HIV/AIDS surveillance data.

Sharafi M, Mirahmadizadeh A, Hassanzadeh J, Seif M, Heiran A Sci Rep. 2024; 14(1):199.

PMID: 38167855 PMC: 10761711. DOI: 10.1038/s41598-023-50713-0.

Perceptions toward antiretroviral therapy and delayed ART initiation among people living with HIV in Changsha, China: mediating effects of treatment willingness.

Zhou Y, Li Y, Xiao X, Qian H, Wang H Front Public Health. 2023; 11:1105208.

PMID: 37383264 PMC: 10294673. DOI: 10.3389/fpubh.2023.1105208.

References

Pacheco P, Zara A, Silva E Souza L, Turchi M . Late Onset of Antiretroviral Therapy in Adults Living with HIV in an Urban Area in Brazil: Prevalence and Risk Factors. J Trop Med. 2019; 2019:5165313. PMC: 6475541. DOI: 10.1155/2019/5165313. View

Anlay D, Tiruneh B, Dachew B . Late ART Initiation among adult HIV patients at university of Gondar Hospital, NorthWest Ethiopia. Afr Health Sci. 2020; 19(3):2324-2334. PMC: 7040303. DOI: 10.4314/ahs.v19i3.4. View

Menezes de Padua C, Braga L, Mendicino C . Adverse reactions to antiretroviral therapy: a prevalent concern. Rev Panam Salud Publica. 2019; 41:e84. PMC: 6660853. DOI: 10.26633/RPSP.2017.84. View

Ameli V, Taj L, Barlow J, Sabin L, Meinck F, Haberer J . 'You just prefer to die early!': how socioecological context impedes treatment for people living with HIV in Iran. BMJ Glob Health. 2021; 6(11). PMC: 8603297. DOI: 10.1136/bmjgh-2021-006088. View

Ruadze E, Chkhartishvili N, Chokoshvili O, Tsertsvadze T . Cascade of care among HIV patients diagnosed in 2013 in Georgia: Risk factors for late diagnosis and attrition from HIV care. SAGE Open Med. 2017; 5:2050312117731977. PMC: 5613841. DOI: 10.1177/2050312117731977. View

Sendagire I, Cobelens F, Kambugu A, Konde-Lule J, Schim van der Loeff M . Frequency and predictors for late start of antiretroviral therapy in primary care clinics, Kampala, Uganda. J Acquir Immune Defic Syndr. 2012; 61(3):e33-9. DOI: 10.1097/QAI.0b013e318265aad7. View

Joulaei H, Motazedian N . Primary Health Care Strategic Key to Control HIV/AIDS in Iran. Iran J Public Health. 2013; 42(5):540-1. PMC: 3684466. View

Gheibi Z, Joulaei H, Fararouei M, Shokoohi M, Foroozanfar Z, Dianatinasab M . Late diagnosis of HIV infection and its associated factors in Shiraz, Southern Iran: a retrospective study. AIDS Care. 2021; 34(10):1321-1329. DOI: 10.1080/09540121.2021.1975629. View

Parcesepe A, Tymejczyk O, Remien R, Gadisa T, Kulkarni S, Hoffman S . Psychological distress, health and treatment-related factors among individuals initiating ART in Oromia, Ethiopia. AIDS Care. 2017; 30(3):338-342. PMC: 5771890. DOI: 10.1080/09540121.2017.1363367. View

10.

Ndawinz J, Chaix B, Koulla-Shiro S, Delaporte E, Okouda B, Abanda A . Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis. J Antimicrob Chemother. 2013; 68(6):1388-99. DOI: 10.1093/jac/dkt011. View

11.

Baker J, Henry W, Neaton J . The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms. Curr Opin HIV AIDS. 2009; 4(3):176-82. PMC: 2879578. DOI: 10.1097/COH.0b013e328329c62f. View

12.

Zarei N, Joulaei H, Darabi E, Fararouei M . Stigmatized Attitude of Healthcare Providers: A Barrier for Delivering Health Services to HIV Positive Patients. Int J Community Based Nurs Midwifery. 2015; 3(4):292-300. PMC: 4591575. View

13.

Najafi Z, Taj L, Dadras O, Ghadimi F, Moradmand B, SeyedAlinaghi S . Epidemiology of HIV in Iran. Curr HIV Res. 2020; 18(4):228-236. DOI: 10.2174/1570162X18666200605152317. View

14.

Sun J, Liu L, Shen J, Chen P, Lu H . Trends in baseline CD4 cell counts and risk factors for late antiretroviral therapy initiation among HIV-positive patients in Shanghai, a retrospective cross-sectional study. BMC Infect Dis. 2017; 17(1):285. PMC: 5395868. DOI: 10.1186/s12879-017-2398-5. View

15.

Gelaw Y, Senbete G, Adane A, Alene K . Determinants of late presentation to HIV/AIDS care in Southern Tigray Zone, Northern Ethiopia: an institution based case-control study. AIDS Res Ther. 2015; 12:40. PMC: 4667535. DOI: 10.1186/s12981-015-0079-2. View

16.

Tang H, Mao Y, Tang W, Han J, Xu J, Li J . "Late for testing, early for antiretroviral therapy, less likely to die": results from a large HIV cohort study in China, 2006-2014. BMC Infect Dis. 2018; 18(1):272. PMC: 5998580. DOI: 10.1186/s12879-018-3158-x. View

17.

Cescon A, Patterson S, Davey C, Ding E, Raboud J, Chan K . Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care. J Int AIDS Soc. 2015; 18:20024. PMC: 4595457. DOI: 10.7448/IAS.18.1.20024. View

18.

Zhang F, Dou Z, Ma Y, Zhang Y, Zhao Y, Zhao D . Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet Infect Dis. 2011; 11(7):516-24. DOI: 10.1016/S1473-3099(11)70097-4. View

19.

Bayisa L, Tadesse A, Reta M, Gebeye E . Prevalence and Factors Associated with Delayed Initiation of Antiretroviral Therapy Among People Living with HIV in Nekemte Referral Hospital, Western Ethiopia. HIV AIDS (Auckl). 2020; 12:457-465. PMC: 7522430. DOI: 10.2147/HIV.S267408. View

20.

SeyedAlinaghi S, Taj L, Mazaheri-Tehrani E, Ahsani-Nasab S, Abedinzadeh N, McFarland W . HIV in Iran: onset, responses, and future directions. AIDS. 2020; 35(4):529-542. PMC: 7924262. DOI: 10.1097/QAD.0000000000002757. View